Alprostadil (20mg)

Description

Alprostadil – Advanced Biochemical Mechanism & Signaling Profile

(Prostaglandin E1 / PGE₁)

Alprostadil is the synthetic form of prostaglandin E1 (PGE₁), a naturally occurring eicosanoid derived from the arachidonic acid cascade. In research models, Alprostadil functions as a G-protein–coupled receptor (GPCR) agonist, primarily activating EP2 and EP4 receptors, leading to cAMP elevation and downstream modulation of smooth-muscle tone, vascular responses, and intracellular signaling programs.

Primary Receptor Targets & Kinetics

Alprostadil interacts with the four known PGE receptors—EP1, EP2, EP3, and EP4, all members of the prostanoid GPCR family.

In most biochemical research, EP2 and EP4 are the dominant pathways for Alprostadil’s activity, producing downstream PKA-mediated signaling alterations.

Second Messenger Systems

When EP2/EP4 are activated:

1. Adenylate Cyclase ↑

2. cAMP accumulation increases

3. PKA activation phosphorylates multiple cytoplasmic and nuclear targets

4. PKA phosphorylates CREB (cAMP response element–binding protein)

5. CREB binds DNA at CRE elements → transcriptional changes

Downstream Gene & Transcriptional Targets

PKA–CREB activation promotes expression of genes involved in:

• Vasodilation & smooth-muscle relaxation

  • eNOS (endothelial nitric oxide synthase)

  • K⁺ channel modulation genes

• Anti-inflammatory signaling

  • IL-10, heme oxygenase-1 (HO-1)

  • Suppression of NF-κB pathway components

• Cyclic nucleotide metabolism

  • PDE-regulated cAMP/cGMP cross-talk

Alprostadil stimulation has been used to study:

• Vascular tone regulation

• Cellular cAMP/cGMP interplay

• Endothelial transcriptional responses

• Cytoskeletal and calcium-dependent contractile proteins

Calcium & IP₃/DAG Signaling (EP1 Pathway)

In cell types expressing EP1:

• Gq activation stimulates phospholipase C (PLC)

• IP₃ mobilizes Ca²⁺ from intracellular stores

• DAG activates PKC

• Studied for roles in contractile protein phosphorylation and myosin light-chain regulation

Opposing Regulation via EP3

EP3 receptor research examines:

• Gi coupling → inhibition of adenylate cyclase

• ↓ cAMP accumulation

• Counterbalance of EP2/EP4 effects

• Transcriptional repression through reduced CREB activation

This provides a model for studying receptor-specific bias and signaling divergence in prostanoid pathways.

Biochemical Research Applications

In controlled in-vitro systems, Alprostadil is used to investigate:

• GPCR receptor bias and second-messenger crosstalk

• PKA-mediated CREB phosphorylation

• eNOS gene regulation and nitric-oxide signaling

• Vascular smooth-muscle relaxation pathways

• PDE-dependent cyclic nucleotide turnover

• Prostaglandin receptor pharmacodynamics

Research-Only Classification

Alprostadil is supplied strictly for laboratory, in-vitro scientific research.
It is not approved for human or animal use, medical treatment, or diagnostic procedures.